NL

Denny Johan Van Den Heuvel

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Denny Johan Van Den Heuvel: Innovator in Pharmaceutical Dosage Units

Introduction

Denny Johan Van Den Heuvel is a notable inventor in the field of pharmaceuticals, particularly known for his work on orodispersible dosage units. He is based in the Netherlands and has made significant contributions to the development of solid pharmaceutical dosage forms.

Latest Patents

Denny has developed innovative patents, including the "Orodispersible Tablet Containing Estetrol." This invention provides an orodispersible solid pharmaceutical dosage unit weighing between 30 and 1,000 mg, containing at least 100 µg of an estetrol component. The process for creating this dosage unit involves mixing an aqueous liquid with carrier particles, removing water, and forming the loaded particles into a solid dosage unit. This formulation is designed for easy manufacturing and is suitable for sublingual, buccal, or sublabial administration. Another patent, "Orodispersible Dosage Unit Containing An Estetrol Component," also focuses on a solid dosage unit with specific weight percentages of estetrol particles and other pharmaceutically acceptable ingredients, emphasizing its ease of manufacture and administration.

Career Highlights

Denny Johan Van Den Heuvel works at Estetra Srl, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the formulation of orodispersible dosage forms, which are crucial for patient compliance and ease of use.

Collaborations

Denny collaborates with esteemed colleagues such as Severine Francine Jaspart and Johannes Jan Platteeuw, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Denny Johan Van Den Heuvel is a prominent figure in the development of orodispersible pharmaceutical dosage units, with a focus on enhancing patient experience through innovative formulations. His contributions to the field are significant and continue to impact pharmaceutical practices positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…